Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Digital Technology for Monitoring Adherence to Inhaled Therapies in People With Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440393/all/Digital_technology_for_monitoring_adherence_to_inhaled_therapies_in_people_with_cystic_fibrosis.
Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440393/all/Digital_technology_for_monitoring_adherence_to_inhaled_therapies_in_people_with_cystic_fibrosis. Accessed February 10, 2025.
Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440393/all/Digital_technology_for_monitoring_adherence_to_inhaled_therapies_in_people_with_cystic_fibrosis
Digital Technology for Monitoring Adherence to Inhaled Therapies in People With Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440393/all/Digital_technology_for_monitoring_adherence_to_inhaled_therapies_in_people_with_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis
ID - 440393
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440393/all/Digital_technology_for_monitoring_adherence_to_inhaled_therapies_in_people_with_cystic_fibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -